JavaScript is disabled in your browser. Please enable JavaScript to view this website.

Licensor patents

ERS Genomics Limited Patent Rights (July 2019)

Granted Patents

Country
Application No.
Filing Date
Patent No.
Grant Date
AU
2013266968
15 Mar 2013
AU 2013266968 B2
07 Dec 2017
CN
201380038920.6
15 Mar 2013
CN 104854241 B
14 Jul 2017
EP
13793997.1
15 Mar 2013
EP 2800811 B1
10 May 2017
EP
17163434.8
15 Mar 2013
EP 3241902 B1
28 Feb 2018
EP
18152360.6
15 Mar 2013
EP 3401400 B1
03 Apr 2019
GB
1420270.9
15 Mar 2013
GB 2518764 C
02 Mar 2016
GB
1601071.2
15 Mar 2013
GB 2537000 B
08 Mar 2017
HK
15106335.4
03 Jul 2015
HK 1207107 B
25 Aug 2017
HK
15112610.8
23 Dec 2015
HK 1211978 B
04 May 2018
HK
17103002.1
03 Jul 2015
HK 1230233 B
01 Jun 2018
JP
20150514015
15 Mar 2013
JP 6343605 B
25 May 2018
MX
20140014477
15 Mar 2013
MX 349744 B
10 Aug 2017
NZ
714353
15 Mar 2013
NZ 714353 B2
29 Aug 2017
SG
11201407702
15 Mar 2013
SG 11201407702X
20 Mar 2017
SG
10201701800Y
15 Mar 2013
SG 10201701800Y
21 Nov 2018
TN
2014/0493
25 Nov 2014
TN 24223
03 Jun 2016
UA
A201413835
15 Mar 2013
UA 118014
12 Nov 2018
US
13/842,859
15 Mar 2013
US 10266850 B2
23 Apr 2019
US
14/685,502
13 Apr 2015
US 10000772 B2
19 Jun 2018
US
14/942,782
16 Nov 2015
US 10227611 B2
12 Mar 2019
US
15/138,604
26 Apr 2016
US 10113167 B2
30 Oct 2018
ZA
2014/07881
29 Oct 2014
ZA 2014/07881
31 Jan 2018
DE
2020132012240.4
15 Mar 2013
DE 202013012240 U1
02 Feb 2016
DE
2020132012241.2
15 Mar 2013
DE 202013012241 U1
18 Jan 2016
DE
2020132012242.0
15 Mar 2013
DE 202013012242 U1
02 Feb 2016

Patent Applications

Country
Application No.
Filing Date
Publication No.
Publication Date
PCT
PCT/US2013/032589
15 Mar 2013
WO 2013/176772 A1
28 Nov 2013
AE
P1296/2014
25 Nov 2014
AU
2017225060
07 Sep 2017
AU 2017225060 A1
28 Sep 2017
AU
2019201850
18 Mar 2019
BR
1120140294410
15 Mar 2013
BR 1120140294410 A2
27 Jun 2017
CA
2872241
15 Mar 2013
CA 2872241 A1
28 Nov 2013
CL
2014003208
25 Nov 2014
CL 2014003208 A1
19 Jun 2015
CN
201710585690.5
15 Mar 2013
CN 107603976 A
19 Jan 2018
CO
20140259531
25 Nov 2014
CO 7151523 A2
29 Dec 2014
CR
20140538
24 Nov 2014
CR 20140538 A
18 Feb 2015
DZ
140780
22 Dec 2014
EA
201401319
15 Mar 2013
EA 201401319 A1
29 May 2015
EC
IEPI-2014-28704
15 Mar 2013
30 Oct 2015
EG
PCT1887/2014
15 Mar 2013
EP
19157590.1
15 Mar 2013
GB
1511669.2
15 Mar 2013
GB 201511669 D0
19 Aug 2015
GE
AP2013013674
15 Mar 2013
HK
15104473.1
12 May 2015
HK 1204003 A1
06 Nov 2015
HK
19119875.3
22 Feb 2019
ID
P00201407783
10 Dec 2014
2016/03367
13 May 2016
IL
235461
15 Mar 2013
31 Dec 2014
IL
261563
15 Mar 2013
31 Oct 2018
IL
261565
15 Mar 2013
31 Oct 2018
IL
261566
15 Mar 2013
31 Oct 2018
IL
261567
15 Mar 2013
31 Oct 2018
IL
261568
15 Mar 2013
31 Oct 2018
IL
261569
15 Mar 2013
31 Oct 2018
IL
261570
15 Mar 2013
31 Oct 2018
IN
2995/KOLNP/2014
15 Mar 2013
2995/KOLNP/2014 A
04 Dec 2015
JP
2018-097369
21 May 2018
2018-138054
06 Sep 2018
KE
P/2014/002178
25 Nov 2014
KR
1020147036096
15 Mar 2013
KR 1020150016588 A
12 Feb 2015
KR
1020177034069
15 Mar 2013
KR 1020170134766 A
06 Dec 2017
KS
P/2017/000022
15 Mar 2013
LY
4958/2014
15 Mar 2013
MA
37663
15 Mar 2013
MA 37663 A1
31 May 2017
MX
2017010309
15 Mar 2013
MX
2019001995
15 Mar 2013
MY
PI2014003102
15 Mar 2013
MY
PI2018700285
15 Mar 2013
NZ
701326
15 Mar 2013
NZ
728024
15 Mar 2013
NZ 728024 A
27 Jan 2017
NZ
730667
15 Mar 2013
NZ 730667 A1
31 Mar 2017
OM
P/2014/00268
25 Nov 2014
PA
90441-01
25 Nov 2014
12 Sep 2016
PE
002211-2014/DIN
15 Mar 2013
PE 03362015 A1
25 Mar 2015
PH
12014502574
19 Nov 2014
PH 12014502574 A1
21 Jan 2015
QA
20141100400
15 Mar 2013
SG
10201809817U
15 Mar 2013
SG 10201809817U A
28 Dec 2018
SY
2014120156
15 Mar 2013
TH
1401007063
15 Mar 2013
TH 173084
15 Feb 2018
UA
A201808549
07 Aug 2018
US
61/652,086
25 May 2012
US
61/716,256
19 Oct 2012
US
61/757,640
28 Jan 2013
US
61/765,576
15 Feb 2013
US
14/403,475
24 Nov 2014
US 2016/0046961 A1
18 Feb 2016
US
14/685,504
13 Apr 2015
US 2016/0130609 A1
12 May 2016
US
14/685,513
13 Apr 2015
US 2016/0060653 A1
03 Mar 2016
US
14/685,514
13 Apr 2015
US 2016/0060654 A1
03 Mar 2016
US
14/685,516
13 Apr 2015
US 2016/0068864 A1
10 Mar 2016
US
15/090,511
04 Apr 2016
US 2017/0051312 A1
23 Feb 2017
US
15/343,156
03 Nov 2016
US
15/343,158
03 Nov 2016
US
15/435,233
16 Feb 2017
US 2017/0166893 A1
15 Jun 2017
US
15/803,424
03 Nov 2017
US 2018/0282764 A1
04 Oct 2018
US
15/915,020
07 Mar 2018
US 2019/0062790 A1
28 Feb 2019
US
15/925,544
19 Mar 2018
US 2018/0208931 A1
26 Jul 2018
US
15/947,680
06 Apr 2018
US 2018/0230495 A1
16 Aug 2018
US
15/947,700
06 Apr 2018
US 2018/0230496 A1
16 Aug 2018
US
15/947,718
06 Apr 2018
US 2018/0230497 A1
16 Aug 2018
US
15/959,715
23 Apr 2018
US 2018/0298406 A1
18 Oct 2018
US
15/959,735
23 Apr 2018
US 2018/0298407 A1
18 Oct 2018
US
15/959,762
23 Apr 2018
US 2018/0237801 A1
23 Aug 2018
US
15/959,782
23 Apr 2018
US 2018/0245100 A1
30 Aug 2018
US
15/959,802
23 Apr 2018
US 2018/0273981 A1
27 Sep 2018
US
15/965,598
27 Apr 2018
US 2018/0245101 A1
30 Aug 2018
US
15/965,603
27 Apr 2018
US 2018/0251791 A1
06 Sep 2018
US
15/981,807
16 May 2018
US 2018/0251793 A1
06 Sep 2018
US
15/981,808
16 May 2018
US 2018/0251794 A1
06 Sep 2018
US
15/981,809
16 May 2018
US 2018/0251795 A1
06 Sep 2018
US
16/033,002
11 Jul 2018
US 2018/0312874 A1
01 Nov 2018
US
16/033,005
11 Jul 2018
US 2018/0312875 A1
01 Nov 2018
US
16/033,016
11 Jul 2018
US 2018/0312876 A1
01 Nov 2018
US
16/136,159
19 Sep 2018
US 2019/0002921 A1
03 Jan 2019
US
16/136,165
19 Sep 2018
US 2019/0002922 A1
03 Jan 2019
US
16/136,168
19 Sep 2018
US 2019/0002923 A1
03 Jan 2019
US
16/136,175
19 Sep 2018
US 2019/0010520 A1
10 Jan 2019
US
16/201,836
27 Nov 2018
US 2019/0093129 A1
28 Mar 2019
US
16/201,848
27 Nov 2018
US 2019/0106711 A1
11 Apr 2019
US
16/201,853
27 Nov 2018
US 2019/0106712 A1
11 Apr 2019
US
16/201,855
27 Nov 2018
US 2019/0106713 A1
11 Apr 2019
US
16/201,862
27 Nov 2018
US 2019/0106714 A1
11 Apr 2019
US
16/201,865
27 Nov 2018
US 2019/0106715 A1
11 Apr 2019
US
16/276,343
14 Feb 2019
US
16/276,348
14 Feb 2019
US
16/276,352
14 Feb 2019
US
16/276,356
14 Feb 2019
US
16/276,361
14 Feb 2019
US
16/276,365
14 Feb 2019
US
16/276,368
14 Feb 2019
US
16/276,374
14 Feb 2019
US
16/277,090
15 Feb 2019
US
16/380,758
10 Apr 2019
US
16/380,781
10 Apr 2019
US
16/382,093
11 Apr 2019
US
16/382,096
11 Apr 2019
US
16/382,097
11 Apr 2019
US
16/382,100
11 Apr 2019
US
16/383,412
12 Apr 2019
US
16/383,422
12 Apr 2019
US
16/383,433
12 Apr 2019
US
16/383,443
12 Apr 2019
US
16/385,360
16 Apr 2019
US
16/385,383
16 Apr 2019
UZ
IAP20140559
15 Mar 2013
VN
1-2014-04335
15 Mar 2013
ZA
2017/00720
30 Jan 2017

Sigma-Aldrich Co. LLC. Patent Rights (August 2019):

REFERENCE / COUNTRY
SERIAL NUMBER / PUBLICATION NUMBER / PATENT NUMBER.
FILING DATE / PUBLICATION DATE / ISSUE DATE
STATUS
SIG202.PRO
61/734,2
06-Dec-2012
Expired
SIG202.PRO2
61/758,624
30-Jan-2013
Expired
SIG202.PRO3
61/761,046
05-Feb-2013
Expired
SIG202.PRO4
61/794,422
15-Mar-2013
Expired
SIG202.PCT
PCT/US2013/073307 WO 2014/089290
5-Dec-2013 12-Jun-2014
Expired
SIG202.USCNT8
15/653,136 (Claims priority from ‘422 Provisional only)
18-Jul-2017
Pending
SIG202.USCNT1
15/188,911 (CON of ‘777) US 2016-0298134 A1
21-Jun-2016
Pending
SIG202.USCNT2
15/188,924 (CON of ‘777) US 2016-0298135 A1
21-Jun-2016
Pending
SIG202.USCNT3
15/188,927 (CON of ‘777) US 2016-0298136 A1
21-Jun-2016
Pending
SIG202.USCNT4
15/188,931 (CON of ‘777) US 2016-0298137 A1
21-Jun-2016
Pending
SIG202.USCNT7
15/456,204 US 2017-0191082 A1
10-Mar-2017
Pending
SIG202.EP
EP13859964.2 EP2928496
5-Dec-2013
Pending
SIG202.EPD3
EP16183723.2 EP3138910 (DIV of ‘964.2) Validated in AT, BE, CZ, DK, EE, FI, FR, DE, IS, IE, IT, LT, LU, NL, NO, PL, PT, SK, ES, SE, CH, TR, GB
5-Dec-2013 20-Sept-2017
Granted
SIG202.EPD4
EP16183724.0 EP3138911 (DIV of ‘964.2) Validated in AT, BE, CZ, DK, EE, FI, FR, DE, IS, IE, IT, LT, LU, NL, NO, PL, PT, SK, ES, SE, CH, TR, GB
5-Dec-2013 5-Dec-2018
Granted
SIG202.EPD5
EP16183725.7 EP3138912 (DIV of ‘964.2) Validated in AT, BE, CZ, DK, EE, FI, FR, DE, IS, IE, IT, LT, LU, NL, NO, PL, PT, SK, ES, SE, CH, TR, GB
5-Dec-2013 5-Dec-2018
Granted
SIG202.EPD6
EP18156734.8 EP3360964
14-Feb-2018 15-Aug-2018
Pending Allowed – not yet granted
SIG202.EPD7
EP18160519.7 EP3363902
9-Mar-2018 22-Aug-2018
Pending
SIG202.AU
2013355214
5-Dec-2013 5-Jul-2018
Granted
SIG202.AU.DIV
2017204031
15-Jun-2017 27-Sept-2018
Granted
SIG202.AU.DIV2
2018229489
12-Sept-2018
Pending Allowed – not yet grated
SIG202.BR
112015012375-9
5-Dec-2013
Pending
SIG202.CA
2,891,347
5-Dec-2013 27-Feb-2018
Granted
SIG202.CA.DIV
2,977,152
5-Dec-2013 9-Apr-2019
Granted
SIG202.CN
201380072477.4 105142669 ZL201380072477.4
5-Dec-2013 3-Jul-2018
Granted
SIG202.CN.DIV1
201810540449.5 108715602
30-May-2018
Pending
SIG202.CN.DIV2
201810574719.4 108913676
6-Jun-2019
Pending
SIG202.HK
16106396.9 1218389A Based upon CN application
5-Dec-2013 17-2-2017
Pending
SIG202.IL
IL238856
5-Dec-2013 30-Jun-2018
Granted
SIG202.IL.DIV
IL257178
5-Dec-2013
Pending
SIG202.IN
1500KOLNP/2015
5-Dec-2013
Pending
SIG202.JP
2015-545838
5-Dec-2013
Pending
SIG202.JPDIV
2017-115672
13-Jun-2017
Pending
SIG202.JPDIV2
2018-183815
28-Sept-2018
Pending
SIG202.KR
10-2015-7013843
5-Dec-2013 26-Mar-2018
Granted
SIG202.KR.DIV
10-2018-7001934
5-Dec-2013
Pending Allowed – not yet granted
SIG202.SG
11201503824S
5-Dec-2013 8-May-2018
Granted
SIG202.SG.DIV
10201800585V
5-Dec-2013
Pending

Broad Institute Patent Rights

EXEMPLARY FAMILY SERIAL NO
PATENT TITLE
PCT/US2013/074611
CRISPR-CAS Component Systems, thods and Compositions for Sequence Manipulation
PCT/US2013/074743
CRISPR-CAS Systems and Methods for Altering Expressions of Gene Products
14/259,420
CRISPR-CAS Systems, Methods and Compositions For Sequence Manipulation in Eukaryotes
PCT/US2013/051418
Inducible DNA Binding Proteins and Genome Perturbation Tools and Applications Thereof
PCT/US2013/074825
Methods, Systems and Apparatus for Identifying Target Sequences for CAS Enzymes or CRISPR-CAS Systems for Target Sequences and Conveying Results Thereof
PCT/US2013/074812
Methods, Models, Systems and Apparatus for Identifying Target Sequences for CAS Enzymes or CRISPR-CAS Systems for Target Sequences and Conveying Results Thereof
PCT/US2013/074667
Delivery, Engineering and Optimization of Systems Methods and Compositions for Sequence Manipulation and Therapeutic Applications
PCT/US2014/041803
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Applications
PCT/US2013/074691
Engineering and Optimization of Improved Systems, Methods and Enzyme Compositions for Sequence Manipulation
PCT/US2013/074736
Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation with Functional Domains
PCT/US2013/074819
Engineering of Systems, Methods and Optimized Guide Compositions for Sequence Manipulation
14/855,046
Recombinant Virus And Preparations Thereof
PCT/US2014/041800
Delivery, Engineering and Optimization of Tandem Guide Systems, Methods and Compositions for Sequence Manipulation
PCT/US2014/041806
Functional Genomics Using CRISPR-Cas Systems, Compositions, Methods, Screens and Applications Thereof
PCT/US2014/064663
CRISPR-Related Methods and Compositions with Governing gRNAS
PCT/US2014/069902
Compositions and Methods of Use of CRISPR-Cas Systems in Nucleotide Repeat Disorders
PCT/US2014/069897
Compositions and Methods of Use of CRISPR-CAS Systems in Nucleotide Repeat Disorders
15/171,141
CRISPR-CAS Systems, Crystal Structure and Uses Thereof
15/349,603
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications
15/467,949
Use and Production of CHD8+/- Transgenic Animals with Behavioral Phenotypes Characteristic of Autism Spectrum Disorder
15/469,081
Functional Screening with Optimized Functional CRISPR-Cas Systems
PCT/US2015/067177
CRISPR Having or Associated with Destabilization Domains
PCT/US2015/065385
Protected Guide RNAs (PGRNAs)
15/632,067
RNA-Targeting System
PCT/US2015/067138
Unbiased Identification of Double- Strand Breaks and Genomic Rearrangement by Genome-Wide Insert Capture Sequencing
PCT/US2015/065393
Dead Guides for CRISPR Transcription Factors
15/619,735
Escorted and Functionalized Guides for CRISPR-CAS Systems
15/619,737
Delivery, Use and Therapeutic Applications of CRISPR Systems and Compositions for Genome Editing as to Hematopoietic Stem Cells (HSCs)
15/640,103
CRISPR MEDIATED IN VIVO MODELING AND GENETIC SCREENING OF TUMOR GROWTH AND METASTASIS
PCT/US2016/038252
Engineering and Optimization of Systems, Methods, Enzymes and Guide Scaffolds of CAS9 Orthologs and Variants for Sequence Manipulation
PCT/US2016/038034
CRISPR Enzyme Mutations Reducing Off-Target Effects
PCT/US2016/038205
CRISPR Mediated Recording of Cellular Events
PCT/US2017/047458
Novel CRISPR Enzymes and Systems
PCT/US2017/053795
Systematic Screening and Mapping of Regulatory Elements in Non-Coding Genomic Regions, Methods, Compositions, and Applications Thereof
62/502,064 62/564,102
Methods for Identification and Modification of LNCRNA Associated with Target Genotypes and Phenotypes
62/529,573
Methods for Designing Guides Sequences for Guided Nucleases
PCT/US2014/070068
CRISPR-CAS Systems and Methods for Altering Expression of Gene Products, Structural Information and Inducible Modular CAS Enzymes
PCT/US2014/041804
DELIVERY AND USE OF THE CRISPR- CAS SYSTEMS, VECTORS AND COMPOSITIONS FOR HEPATIC TARGETING AND THERAPY
PCT/US2014/070127
Delivery, Use and Therapeutic Applications of the CRISPR-Cas Systems and Compositions for Genomic Editing
PCT/US2014/041808
Delivery, Engineering and Optimization of Systems, Methods and Compositions for Targeting and Modeling Diseases and Disorders of Post Mitotic Cells
PCT/US2014/041809
Delivery, Use and therapeutic Applications of the CRISPR-Cas systems and Compositions for Targeting Disorders and Diseases Using Viral Components
PCT/US2014/070057
Delivery, Use and Therapeutic Applications of the CRISPR-CAS Systems and Compositions for Targeting Disorders and Diseases Using NanoParticle Components
PCT/US2013/074800
Functional Genomics Using CRISPR- CAS Systems, Compositions, Methods, Knock Out Libraries and Applications Thereof
PCT/US2014/070152
Engineering Of Systems, Methods And Optimized Guide Compositions with New Architectures For Sequence Manipulation
PCT/US2014/070175
Systems, Methods and Compositions for Sequence Manipulation with Optimized Functional CRISPR-CAS Systems
PCT/US2015/045504
Genome Editing Using CAS9 Nickases
15/467,888
Delivery, Use and Therapeutic Applications of the CRISPR-CAS Systems and Compositions for Modeling Competition of Multiple Cancer Mutations in Vivo